Printer Friendly

Articles from M2 Pharma (July 13, 2018)

1-25 out of 25 article(s)
Title Author Type Words
Abbott awarded US FDA's approval for MitraClip heart valve repair device. 297
AbbVie fails to meet goal in DBL3001 trial of Ibrutinib (IMBRUVICA). 232
Aeromics Begins Phase 1 Trial of Anti-Edema Therapy in Ischemic Stroke. 225
Alveo discloses two senior appointments. 163
Amgen & UCB partnership submits EVENITY BLA with the US FDA for treating osteoporosis. 271
Bio-Techne Uses CRISPR Gene Editing System to Validate Antibodies in KO Cell Lines. 270
Bruker closes acquisition of JPK Instruments AG for undisclosed fee. 207
Cellect Secures Supply of Key Component in Agreement with Swiss Biotech. 207
Citius Updates Progress on Test Site Acquisition for Mino-lok Phase 3 Trial. 242
Clementia names new CFO. 195
Enzyvant Begins Rolling Submission of BLA for Single Administration cDGA Treatment. 190
European, Canadian Patents Issued for Thermostable Ricin Toxin Vaccine from Soligenix. 223
GSK confirms deal with Dermavent Sciences. 155
Guardant Health names new general manager of its LUNAR program. 160
Inscripta awarded patents for CRISPR gene-editing systems, the MAD7 & MAD2. 200
MabVax Licenses Glycan-Targeting Antibody Series to Boehringer Ingelheim. 235
Mallinckrodt Completes Database Studies on TKA Recovery After IV Acetaminophen. 295
ObsEva starts trading on SIX Swiss Exchange. 176
Onxeo reports new preclinical results on AsiDNA. Financial report 258
Otsuka Pharmaceutical acquires Visterra. 130
Progress Updated in Clinical Trials of Enfortumab Vedotin for Urothelial Cancer. 323
Takeda and Norgine terminate licence and development agree for OBLEAN tablets. 168
US FDA approves Abbott's new MitraClip heart valve repair device. 205
US FDA grants Merck's Keytruda priority review for new supplemental biologics license application. 170
WuXi Biologics to Manufacture Monoclonal Antibody Bertilimumab for Immune Pharma. 228

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters